Reade De Leacy, MBBS
Surgery — Icahn School of Medicine at Mount Sinai, United States
Reade De Leacy
LeadR Profile
Surgery
Subspecialties: Cardiology - Neurology - Medical Imaging
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
Reade De Leacy, MD, is an Associate Professor of Neurosurgery and Radiology at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Cerebrovascular Center. He serves as Director of Cerebrovascular Services at Mount Sinai West, Director of the Neurointerventional Spine Program, and Co-Director of the Neuroendovascular Surgery Fellowship at Mount Sinai.
A specialist in diagnostic and interventional neuroradiology, Dr. De Leacy is board certified in both diagnostic radiology and neuroradiology by the American Board of Radiology. He completed his fellowship trainings in neuroendovascular surgery/neurointerventional radiology and separately diagnostic neuroradiology at The Mount Sinai Hospital. He also completed fellowship training in interventional radiology at St. Vincent’s Hospital in Melbourne, Australia and in musculoskeletal MRI and sports medicine intervention with Qscan Radiology Clinics in Queesnland, Australia.
Dr. De Leacy obtained his medical degree and graduated with honors from the University of Queensland, Australia. In 2012, he completed his specialist training becoming a fellow of the Royal Australian and New Zealand College of Radiologists, where he earned the prestigious Uhr Clarke Bursary and HR Sear Prize awards as the highest-ranked graduate from both diagnostic radiology and radiation oncology in Australia, New Zealand, and Singapore.
Dr. De Leacy has published multiple peer-reviewed journal articles and book chapters in interventional neuroradiology and neuroendovascular surgery. He has served on the executive board of the Society of Neurointerventional Surgery (SNIS) and is an associate editor for the Journal of Neurointerventional Surgery (JNIS). He lectures and teaches across the world on neurovascular neurovascular and spine interventional techniques.
Dr. De Leacy specializes in the endovascular treatment of cerebrovascular disorders including cerebral aneurysms, arteriorvenous malformations of both the brain and head and neck, dural arteriovenous malformations of the brain, acute stroke and carotid disease including carotid stenosis. He is experienced with all head and neck vascular intervention including tumor embolization and scelrotherpay for lymphatic and venous malformations. Additionally he has extensive expereince in complex interventional spine procedures for vertebral fractures, tumors and other procedures for low back pain including indirect spinal decompression, sacroliliac joint fusion and spinal cord stimulation.
In 2020, Dr. De Leacy was a recipient of the Mount Sinai Cullman Family Award for Excellence in Physician Communication.
Organizations
Career arc: 2006 - 2026
Number : 290
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
Clinical Studies 13
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Diagnostic Performance Study of the EMVision Emu Brain Scanner in the Detection of Intracranial Hemorrhage in Suspected Stroke Patients NCT06999122 — safety, hemorrhage, blood, stroke, brain, hemorrhagic stroke, multiple chronic conditions, intracranial hemorrhages, diagnosis, tissues, head | N/A | Recruiting | 2025 |
| Kaneka iED Coil System for the Treatment of Wide Necked Ruptured and Unruptured Intracranial Aneurysms NCT05636124 — safety, aneurysm, arteriovenous malformations, therapeutics, intracranial aneurysm, neck | N/A | Active not recruiting | 2023 |
| EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE MeVO Trial) NCT05151172 — safety, blood, ischemic stroke, stroke, pharmaceutical preparations, blood pressure, fibrinolytic agents, intracranial thrombosis, coagulants, therapeutics, thrombosis, thrombectomy, blood vessels | N/A | Active not recruiting | 2022 |
LeadR Networks
Main global connection map